Literature DB >> 27846599

Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting.

Katelyn M Gostic1, Monique Ambrose1, Michael Worobey2, James O Lloyd-Smith3,4.   

Abstract

Two zoonotic influenza A viruses (IAV) of global concern, H5N1 and H7N9, exhibit unexplained differences in age distribution of human cases. Using data from all known human cases of these viruses, we show that an individual's first IAV infection confers lifelong protection against severe disease from novel hemagglutinin (HA) subtypes in the same phylogenetic group. Statistical modeling shows that protective HA imprinting is the crucial explanatory factor, and it provides 75% protection against severe infection and 80% protection against death for both H5N1 and H7N9. Our results enable us to predict age distributions of severe disease for future pandemics and demonstrate that a novel strain's pandemic potential increases yearly when a group-mismatched HA subtype dominates seasonal influenza circulation. These findings open new frontiers for rational pandemic risk assessment.
Copyright © 2016, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27846599      PMCID: PMC5134739          DOI: 10.1126/science.aag1322

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  61 in total

1.  Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.

Authors:  Tom M Wilkinson; Chris K F Li; Cecilia S C Chui; Arthur K Y Huang; Molly Perkins; Julia C Liebner; Rob Lambkin-Williams; Anthony Gilbert; John Oxford; Ben Nicholas; Karl J Staples; Tao Dong; Daniel C Douek; Andrew J McMichael; Xiao-Ning Xu
Journal:  Nat Med       Date:  2012-01-29       Impact factor: 53.440

2.  Epidemiological evidence of an early wave of the 1918 influenza pandemic in New York City.

Authors:  Donald R Olson; Lone Simonsen; Paul J Edelson; Stephen S Morse
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-26       Impact factor: 11.205

3.  RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models.

Authors:  Alexandros Stamatakis
Journal:  Bioinformatics       Date:  2006-08-23       Impact factor: 6.937

4.  Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases.

Authors:  Benjamin J Cowling; Lianmei Jin; Eric H Y Lau; Qiaohong Liao; Peng Wu; Hui Jiang; Tim K Tsang; Jiandong Zheng; Vicky J Fang; Zhaorui Chang; Michael Y Ni; Qian Zhang; Dennis K M Ip; Jianxing Yu; Yu Li; Liping Wang; Wenxiao Tu; Ling Meng; Joseph T Wu; Huiming Luo; Qun Li; Yuelong Shu; Zhongjie Li; Zijian Feng; Weizhong Yang; Yu Wang; Gabriel M Leung; Hongjie Yu
Journal:  Lancet       Date:  2013-06-24       Impact factor: 79.321

5.  Differences in the Epidemiology of Human Cases of Avian Influenza A(H7N9) and A(H5N1) Viruses Infection.

Authors:  Ying Qin; Peter W Horby; Tim K Tsang; Enfu Chen; Lidong Gao; Jianming Ou; Tran Hien Nguyen; Tran Nhu Duong; Viktor Gasimov; Luzhao Feng; Peng Wu; Hui Jiang; Xiang Ren; Zhibin Peng; Sa Li; Ming Li; Jiandong Zheng; Shelan Liu; Shixiong Hu; Rongtao Hong; Jeremy J Farrar; Gabriel M Leung; George F Gao; Benjamin J Cowling; Hongjie Yu
Journal:  Clin Infect Dis       Date:  2015-05-04       Impact factor: 9.079

6.  Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells.

Authors:  Gui-Mei Li; Christopher Chiu; Jens Wrammert; Megan McCausland; Sarah F Andrews; Nai-Ying Zheng; Jane-Hwei Lee; Min Huang; Xinyan Qu; Srilatha Edupuganti; Mark Mulligan; Suman R Das; Jonathan W Yewdell; Aneesh K Mehta; Patrick C Wilson; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-21       Impact factor: 11.205

7.  The transmissibility and control of pandemic influenza A (H1N1) virus.

Authors:  Yang Yang; Jonathan D Sugimoto; M Elizabeth Halloran; Nicole E Basta; Dennis L Chao; Laura Matrajt; Gail Potter; Eben Kenah; Ira M Longini
Journal:  Science       Date:  2009-09-10       Impact factor: 47.728

8.  Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis.

Authors:  Matthew S Miller; Thomas J Gardner; Florian Krammer; Lauren C Aguado; Domenico Tortorella; Christopher F Basler; Peter Palese
Journal:  Sci Transl Med       Date:  2013-08-14       Impact factor: 17.956

9.  Social contact patterns in Vietnam and implications for the control of infectious diseases.

Authors:  Peter Horby; Quang Thai Pham; Niel Hens; Thi Thu Yen Nguyen; Quynh Mai Le; Dinh Thoang Dang; Manh Linh Nguyen; Thu Huong Nguyen; Neal Alexander; W John Edmunds; Nhu Duong Tran; Annette Fox; Tran Hien Nguyen
Journal:  PLoS One       Date:  2011-02-14       Impact factor: 3.240

10.  Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA.

Authors:  Laura Forsberg White; Jacco Wallinga; Lyn Finelli; Carrie Reed; Steven Riley; Marc Lipsitch; Marcello Pagano
Journal:  Influenza Other Respir Viruses       Date:  2009-11       Impact factor: 4.380

View more
  166 in total

Review 1.  Immune history and influenza virus susceptibility.

Authors:  Sarah Cobey; Scott E Hensley
Journal:  Curr Opin Virol       Date:  2017-01-12       Impact factor: 7.090

2.  Immunodominance and Antigenic Variation of Influenza Virus Hemagglutinin: Implications for Design of Universal Vaccine Immunogens.

Authors:  Seth J Zost; Nicholas C Wu; Scott E Hensley; Ian A Wilson
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226

Review 3.  Opportunities and challenges in modeling emerging infectious diseases.

Authors:  C Jessica E Metcalf; Justin Lessler
Journal:  Science       Date:  2017-07-14       Impact factor: 47.728

4.  Dynamic Perspectives on the Search for a Universal Influenza Vaccine.

Authors:  Chadi M Saad-Roy; Adrian B McDermott; Bryan T Grenfell
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226

5.  Anomalous influenza seasonality in the United States and the emergence of novel influenza B viruses.

Authors:  Rebecca K Borchering; Christian E Gunning; Deven V Gokhale; K Bodie Weedop; Arash Saeidpour; Tobias S Brett; Pejman Rohani
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-02       Impact factor: 11.205

6.  Age-specific effects of vaccine egg adaptation and immune priming on A(H3N2) antibody responses following influenza vaccination.

Authors:  Feng Liu; F Liaini Gross; Stacie N Jefferson; Crystal Holiday; Yaohui Bai; Li Wang; Bin Zhou; Min Z Levine
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808

7.  Reply to Shanks and Brundage: Many plausible mechanisms of pandemic mortality disparities.

Authors:  Kyra H Grantz; Madhura S Rane; Henrik Salje; Gregory E Glass; Stephen E Schachterle; Derek A T Cummings
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-06       Impact factor: 11.205

Review 8.  From Original Antigenic Sin to the Universal Influenza Virus Vaccine.

Authors:  Carole Henry; Anna-Karin E Palm; Florian Krammer; Patrick C Wilson
Journal:  Trends Immunol       Date:  2017-08-31       Impact factor: 16.687

9.  Association of Prior Vaccination With Influenza Vaccine Effectiveness in Children Receiving Live Attenuated or Inactivated Vaccine.

Authors:  Huong Q McLean; Herve Caspard; Marie R Griffin; Manjusha Gaglani; Timothy R Peters; Katherine A Poehling; Christopher S Ambrose; Edward A Belongia
Journal:  JAMA Netw Open       Date:  2018-10-05

Review 10.  Immunological responses to influenza vaccination: lessons for improving vaccine efficacy.

Authors:  Taia T Wang; Stylianos Bournazos; Jeffrey V Ravetch
Journal:  Curr Opin Immunol       Date:  2018-05-10       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.